163 related articles for article (PubMed ID: 32301137)
1. Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data.
Camilleri M; Lembo A; McCallum R; Tourkodimitris S; Kemps L; Miller MB; Bertelsen K; Iacob A
Aliment Pharmacol Ther; 2020 Jun; 51(11):1139-1148. PubMed ID: 32301137
[TBL] [Abstract][Full Text] [Related]
2. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Camilleri M; McCallum RW; Tack J; Spence SC; Gottesdiener K; Fiedorek FT
Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
[TBL] [Abstract][Full Text] [Related]
4. Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.
McCallum RW; Lembo A; Esfandyari T; Bhandari BR; Ejskjaer N; Cosentino C; Helton N; Mondou E; Quinn J; Rousseau F;
Neurogastroenterol Motil; 2013 Nov; 25(11):e705-17. PubMed ID: 23848826
[TBL] [Abstract][Full Text] [Related]
5. Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist.
Camilleri M; Acosta A
Neurogastroenterol Motil; 2015 Mar; 27(3):324-32. PubMed ID: 25545036
[TBL] [Abstract][Full Text] [Related]
6. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial.
Acosta A; Camilleri M; Kolar G; Iturrino J; Szarka LA; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR; Spence SC; Gottesdiener K; Bouras EP; Vazquez-Roque MI
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2312-9.e1. PubMed ID: 26001337
[TBL] [Abstract][Full Text] [Related]
7. Treatment With a Ghrelin Agonist in Outpatient Women With Anorexia Nervosa: A Randomized Clinical Trial.
Fazeli PK; Lawson EA; Faje AT; Eddy KT; Lee H; Fiedorek FT; Breggia A; Gaal IM; DeSanti R; Klibanski A
J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29325236
[TBL] [Abstract][Full Text] [Related]
8. Relamorelin for the treatment of gastrointestinal motility disorders.
Chedid V; Camilleri M
Expert Opin Investig Drugs; 2017 Oct; 26(10):1189-1197. PubMed ID: 28847163
[TBL] [Abstract][Full Text] [Related]
9. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis.
Ejskjaer N; Wo JM; Esfandyari T; Mazen Jamal M; Dimcevski G; Tarnow L; Malik RA; Hellström PM; Mondou E; Quinn J; Rousseau F; McCallum RW
Neurogastroenterol Motil; 2013 Feb; 25(2):e140-50. PubMed ID: 23279217
[TBL] [Abstract][Full Text] [Related]
10. Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers.
Nelson AD; Camilleri M; Acosta A; Busciglio I; Linker Nord S; Boldingh A; Rhoten D; Ryks M; Burton D
Neurogastroenterol Motil; 2016 Nov; 28(11):1705-1713. PubMed ID: 27283792
[TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trial: A phase 2b controlled study of the efficacy and safety of trazpiroben (TAK-906) for idiopathic or diabetic gastroparesis.
Tack J; McCallum R; Kuo B; Huh SY; Zhang Y; Chen YJ; Mehrotra S; Parkman HP
Neurogastroenterol Motil; 2023 Oct; 35(10):e14652. PubMed ID: 37533380
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis.
Ejskjaer N; Vestergaard ET; Hellström PM; Gormsen LC; Madsbad S; Madsen JL; Jensen TA; Pezzullo JC; Christiansen JS; Shaughnessy L; Kosutic G
Aliment Pharmacol Ther; 2009 Jun; 29(11):1179-87. PubMed ID: 19298585
[TBL] [Abstract][Full Text] [Related]
13. Relamorelin in Gastroparesis and Diabetic Gastroparesis: A Meta-Analysis on Its Efficacy and Safety.
Patel A; Arora GS; Roknsharifi M; Javed H; Kaur P
Cureus; 2023 Nov; 15(11):e48303. PubMed ID: 38058346
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
[TBL] [Abstract][Full Text] [Related]
15. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial.
Pratley R; Amod A; Hoff ST; Kadowaki T; Lingvay I; Nauck M; Pedersen KB; Saugstrup T; Meier JJ;
Lancet; 2019 Jul; 394(10192):39-50. PubMed ID: 31186120
[TBL] [Abstract][Full Text] [Related]
16. Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial.
Goadsby PJ; Dodick DW; Ailani J; Trugman JM; Finnegan M; Lu K; Szegedi A
Lancet Neurol; 2020 Sep; 19(9):727-737. PubMed ID: 32822633
[TBL] [Abstract][Full Text] [Related]
17. Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 study.
Kuo B; Barnes CN; Nguyen DD; Shaywitz D; Grimaldi M; Renzulli C; Canafax D; Parkman HP
Aliment Pharmacol Ther; 2021 May; 53(10):1090-1097. PubMed ID: 33811761
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
[TBL] [Abstract][Full Text] [Related]
19. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.
Murray CD; Martin NM; Patterson M; Taylor SA; Ghatei MA; Kamm MA; Johnston C; Bloom SR; Emmanuel AV
Gut; 2005 Dec; 54(12):1693-8. PubMed ID: 16085693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
